Details of the Drug

General Information of Drug (ID: DMXBCTE)

• Drug Name: DPIV/CD26

Indication

Disease Entry	ICD 11	Status	REF
Acne vulgaris	ED80	Phase 2	[1]

• Cross-matching ID: TTD ID: D06DSQ

References

• [1] ClinicalTrials.gov (NCT00824980) Combined Inhibition of Dipeptidyl Peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/CD13) in the Treatment of Psoriasis. U.S. National Institutes of Health.